CGC
Canopy Growth Corporation·Healthcare
1.05
3.670%(−0.04)
Market ClosedLast Updated: — ET
52W L: $0.8452W H: $2.38
CGC NEWS
marijuanastocks.com
1d ago
3 Canadian Marijuana Stocks For Better Cannabis Investing 2026
Marijuana stock investors who have been trading and holding over the years know this sector holds potential. Now, potential doesn't put money in your pocket, but progressive and profitable companies that make up the industry can, which means that there is a lot of potential to see big gains in the future with all that is taking place. For the USA, there are only a few states that have yet to legalize cannabis. Just the legal states alone in 2026 have brought in a billion in revenue.
zacks.com
3d ago
Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Canopy Growth (CGC). This makes it worthwhile to examine what the stock has in store.
zacks.com
4d ago
Canopy Growth Corporation (CGC) Beats Stock Market Upswing: What Investors Need to Know
In the latest trading session, Canopy Growth Corporation (CGC) closed at $1.02, marking a +2% move from the previous day.
marijuanastocks.com
Mar 31
Best Canadian Cannabis Stocks for Potential Breakouts in March 2026
The Canadian cannabis sector continues evolving as global opportunities expand. Many companies are now positioning for U.S. entry. Additionally, federal reform discussions in the United States remain a major catalyst. As a result, investors are closely watching key Canadian names. However, volatility remains high, so proper risk management is essential.
businesswire.com
Mar 31
Canopy Growth Unveils New Brand ‘Deelish': High THC, Everyday Price
SMITH FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) today announced Deelish ("DEE-LISH"), a new cannabis brand built for the everyday consumer with an everyday price. Deelish enters the market built to deliver high THC with flower testing at 27%-33% THC and pre-rolls at 26%-32% THC. And unlike brands built around a single profile, Deelish rotates its genetic lineup regularly, giving consumers access to a curated range of.
fool.com
Mar 30
Thinking About Buying Canopy Growth Stock? You May Want to Wait for This to Happen First
Marijuana legalization in the U.S. isn't likely to happen anytime soon, and that's weighing on Canopy Growth's stock. The company's results have been abysmal, and there's little reason to be optimistic that they'll improve anytime soon.
